Jin Soo Joo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jin Soo Joo has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Jun Young Hong
Department of Systems Biology, Yonsei University, Seoul 03722, Korea
2 shared publications - Dongeun Lee
Department of Systems Biology, Yonsei University, Seoul 03722, Korea
1 shared publication Lesley Pasman
Department of Immunobiology, Yale University School of Medicine , New Haven, CT 06510
1 shared publicationPhilippe Naquet
Centre D'Immunologie de Marseille-Luminy, INSERM, CNRS, Aix-Marseille Université , 13288 Marseille , France
1 shared publication- Robert Homer
Department of Pathology, Yale School of Medicine, New Haven, USA
1 shared publication - Ruslan Medzhitov
Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA
1 shared publication
Latest Publications
- Open Access
- 30 May 2026
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 5 (6) , pgag222
Vanin-1 deficiency enhances host tolerance to influenza infection by modulating cellular redox status
Host survival during infection depends on the balance between pathogen resistance and tissue tolerance mechanisms. Although resistance pathways are well characterized, the molecular determinants of host tolerance remain poorly understood. Here, we demonstrate that vanin-1, an ectoenzyme known for its role in vitamin B5 metabolism, unexpectedly regulates host tolerance during influenza infection through modulation of cellular redox status. Mice lacking vanin-1 showed enhanced survival following lethal influenza infection without alterations in viral burden, immune responses, or tissue pathology. While vanin-1 deficiency impairs vitamin B5 metabolism, neither vitamin B5 supplementation nor deficiency affected survival during infection, indicating a vitamin B5–independent mechanism. RNA sequencing analysis revealed enhanced expression of antioxidant pathway genes in vanin-1–deficient mice, with Nrf2 serving as a key upstream regulator. Mechanistically, vanin-1–deficient mice maintained higher glutathione levels during infection and showed reduced lipid peroxidation, suggesting protection against oxidative stress-induced cell death. Importantly, pharmacological inhibition of glutathione synthesis abolished the survival advantage in vanin-1–deficient mice, while glutathione supplementation protected wild-type mice from lethal infection. Our findings reveal an unexpected role for vanin-1 in regulating host tolerance through antioxidant pathways and identify a potential therapeutic target for enhancing survival during severe viral infections.
- 30 May 2026
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 5 (6) , pgag222
Open AccessVanin-1 deficiency enhances host tolerance to influenza infection by modulating cellular redox status
Host survival during infection depends on the balance between pathogen resistance and tissue tolerance mechanisms. Although resistance pathways are well characterized, the molecular determinants of host tolerance remain poorly understood. Here, we demonstrate that vanin-1, an ectoenzyme known for its role in vitamin B5 metabolism, unexpectedly regulates host tolerance during influenza infection through modulation of cellular redox status. Mice lacking vanin-1 showed enhanced survival following lethal influenza infection without alterations in viral burden, immune responses, or tissue pathology. While vanin-1 deficiency impairs vitamin B5 metabolism, neither vitamin B5 supplementation nor deficiency affected survival during infection, indicating a vitamin B5–independent mechanism. RNA sequencing analysis revealed enhanced expression of antioxidant pathway genes in vanin-1–deficient mice, with Nrf2 serving as a key upstream regulator. Mechanistically, vanin-1–deficient mice maintained higher glutathione levels during infection and showed reduced lipid peroxidation, suggesting protection against oxidative stress-induced cell death. Importantly, pharmacological inhibition of glutathione synthesis abolished the survival advantage in vanin-1–deficient mice, while glutathione supplementation protected wild-type mice from lethal infection. Our findings reveal an unexpected role for vanin-1 in regulating host tolerance through antioxidant pathways and identify a potential therapeutic target for enhancing survival during severe viral infections.
- Top Cited PapersOpen Access
- 1 January 2024
- Published by XMLink in Immune Network
- Vol. 24 (4) , e30
Multi-Layered Mechanisms of Immunological Tolerance at the Maternal-Fetal Interface
Joo JS, et al. Immune Netw. 2024 Jul;24(4):e30. https://doi.org/10.4110/in.2024.24.e30
- 1 January 2024
- Published by XMLink in Immune Network
- Vol. 24 (4) , e30
Top Cited PapersOpen AccessMulti-Layered Mechanisms of Immunological Tolerance at the Maternal-Fetal Interface
Joo JS, et al. Immune Netw. 2024 Jul;24(4):e30. https://doi.org/10.4110/in.2024.24.e30